Literature DB >> 20847749

Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008.

C Bunce1, W Xing, R Wormald.   

Abstract

PURPOSE: The last complete report on causes of blindness in England and Wales was for the data collected during April 1999-March 2000. This study updates these figures, with data collected during April 2007-March 2008.
METHODS: In England and Wales, registration for blindness and partial sight is initiated with certification by a consultant ophthalmologist with the consent of the patient. The main cause of visual impairment was ascertained where possible for all certificates completed during April 2007-March 2008 and a proportional comparison with 1999-2000 figures was made.
RESULTS: We received 23,185 Certificates of Vision Impairment (CVIs), of which 9823 were for severe sight impairment (blindness) (SSI) and 12,607 were for sight impairment (partial sight) (SI). These totals were considerably lower than the numbers certified in the year ending 31 March 2000. In 16.6% of CVIs, there were multiple causes of visual impairment as compared with 3% of BD8s in 2000. Degeneration of the macula and posterior pole (mostly age-related macular degeneration (AMD)) contributed to vision impairment in 12,746 newly certified blind or partially sighted.
CONCLUSIONS: AMD is still by far the leading cause of certified visual loss in England and Wales. Proportional comparisons are hampered by the increasing use of multiple pathology as a main cause of visual impairment, which is believed to have arisen owing to the change in certificate used for data collection. These figures are not estimates of the total numbers newly blind in the UK because not all those entitled to certification are offered and or accept it, but they do nevertheless document the number of people who are deemed to be sufficiently sight impaired to warrant support and have been both offered and accepted it. This is usually the case when no further ophthalmic intervention is thought likely to be of benefit in terms of restoring or improving vision.

Entities:  

Mesh:

Year:  2010        PMID: 20847749     DOI: 10.1038/eye.2010.122

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  71 in total

1.  The accuracy of home monitoring to detect disease activity during maintenance therapy for neovascular ARMD.

Authors:  Martin McKibbin; Lucy Baker; Paul Baxter; Carolyn Czoski-Muray; Roopa Setty
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-05       Impact factor: 3.117

2.  Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema: a meta-analysis.

Authors:  Xiao-Ling Zhang; Jian Chen; Ri-Jia Zhang; Wen-Jie Wang; Qing Zhou; Xiao-Yan Qin
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

3.  Early spatiotemporal characterization of microglial activation in the retinas of rats with streptozotocin-induced diabetes.

Authors:  Xiaofei Chen; Huanfen Zhou; Yan Gong; Shihui Wei; Maonian Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-13       Impact factor: 3.117

4.  Response to Bunce et al. Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008.

Authors:  M J Wakefield; D M Tole; C C Bailey; M V Mundasad; J M Sparrow
Journal:  Eye (Lond)       Date:  2011-02-25       Impact factor: 3.775

5.  Natural history of retinopathy in children and young people with type 1 diabetes.

Authors:  N Dhillon; A Karthikeyan; A Castle; P Dodson; W Högler; J Kirk; N Krone; J Nolan; T Barrett
Journal:  Eye (Lond)       Date:  2016-04-22       Impact factor: 3.775

6.  Trends in serious ocular trauma in Scotland.

Authors:  P Desai; D S Morris; D C Minassian; C J MacEwen
Journal:  Eye (Lond)       Date:  2015-02-13       Impact factor: 3.775

7.  Intravitreal aflibercept for neovascular age-related macular degeneration in patients aged 90 years or older: 2-year visual acuity outcomes.

Authors:  Irini Chatziralli; Shane O Regan; Ryian Mohamed; James Talks; Sobha Sivaprasad
Journal:  Eye (Lond)       Date:  2018-06-04       Impact factor: 3.775

8.  Comparison of central corneal thickness measurements obtained by community optometrists to those obtained in secondary care.

Authors:  Laura Hughes; Cheng Yi Loo; Brian Hogan; Huai Ling Tan; Ling Shan Tang; Andrew J Tatham
Journal:  Eye (Lond)       Date:  2018-07-23       Impact factor: 3.775

9.  [Epidemiology of severe visual impairment and blindness of old people in Germany].

Authors:  M M Mauschitz; J Q Li; P P Larsen; J Köberlein-Neu; F G Holz; M M B Breteler; R P Finger
Journal:  Ophthalmologe       Date:  2019-02       Impact factor: 1.059

Review 10.  Sight-threatening diabetic eye disease: an update and review of the literature.

Authors:  Richard J Symes; Gerald Liew; Adnan Tufail
Journal:  Br J Gen Pract       Date:  2014-10       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.